Valeant nears deal for 'female Viagra' maker Sprout: WSJ

Canada's Valeant Pharmaceuticals International Inc is nearing a deal to pay $1 billion for Sprout Pharmaceuticals, the company that just won approval to sell the first drug that aims to boost a woman's libido, the Wall Street Journal reported.

DealsNorth AmericaUSBriefs